Need professional-grade analysis? Visit stockanalysis.com
$6.08B
12.43
3,578
1.62%
China Isotope Radiation Corporation (1763) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD18.66, down 0.74% from the previous close.
Over the past year, 1763 has traded between a low of HKD10.90 and a high of HKD24.40. The stock has gained 68.5% over this period. It is currently 23.5% below its 52-week high.
China Isotope Radiation Corporation has a market capitalization of $6.08B, with a price-to-earnings ratio of 12.43 and a dividend yield of 1.62%.
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic, and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test kits and analyzers. The Radioactive Source Products segment sells medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization, and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities and related technical services. The Radiation Therapy Equipment and Related Services segment sells nuclear medical equipment and provides related maintenance services. The Other Businesses segment provides independent clinical laboratory services for nuclear technology industry applications and medical product applications; and provides radioactive source, medical nuclides, imported radiopharmaceuticals, nuclear instruments and devices, medical equipment and other products. In addition, the company provides irradiation service for sterilization; and research, development, production, and sales of irradiation modified materials. The company was incorporated in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
Side-by-side comparison against top Healthcare peers.